why choose us

First received: February 10, 2023

Clinical Trial: Observational Study of Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Lymphocytic Leukemia (CLL)

Study Type: OBSERVATIONAL


Official Title: Observational Study of Cardiac Arrhythmias in CLL Subjects Treated With BTK Inhibitors or Venetoclax

Brief Summary: Background:Bruton s tyrosine kinase inhibitors (BTKi) are used to treat a form of leukemia.But taking BTKi can also increase a person s risk of developing an abnormal heart rhythm.This can cause sudden death.In this natural history study, researchers want to learn how BTKi affects the heart.Objective:To identify and monitor the effects of BTKi on the heart.Eligibility:People aged 18 and older currently receiving or planning to receive BTKi or venetoclax.Design:Participants who have not yet started BTKi will have 2…

Read more